Munich, Germany

Thomas Mueller

This inventor holds 1 USPTO granted patent. Top assignee: Affimed Gmbh. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Mueller. Retrieved from https://idiyas.com/inventor/thomas-mueller-rskgq8rn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Mueller - Innovator in Antibody Technology

Introduction

Thomas Mueller is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody molecules. His work has the potential to advance therapeutic applications in various medical fields.

Latest Patents

Thomas Mueller holds 1 patent for his invention titled "Multivalent FV antibodies." This patent pertains to a trispecific antibody molecule that may comprise a diabody-unit integrated into a polypeptide chain with at least six variable domains linked sequentially. In certain instances, two single-chain Fv (scFv) fragments are distally connected to the diabody-unit, providing two additional antigen binding sites.

Career Highlights

Thomas Mueller is currently employed at Affimed GmbH, a company known for its innovative approaches in immuno-oncology. His work at Affimed has allowed him to explore and develop cutting-edge antibody technologies that can potentially transform treatment methodologies.

Collaborations

Throughout his career, Thomas has collaborated with talented professionals, including Kristina Ellwanger and Ivica Fucek. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in antibody research.

Conclusion

Thomas Mueller's contributions to the field of antibody technology exemplify the innovative spirit of modern science. His work continues to pave the way for new therapeutic solutions in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…